|
Volumn 64, Issue 3, 2011, Pages 237-239
|
Repeated daclizumab administration to delay the introduction of calcineurin inhibitors in heart transplant patients with postoperative renal dysfunction;Dosis repetidas de daclizumab para retrasar la instauración del inhibidor de la calcineurina en pacientes con trasplante cardiaco y disfunción renal postoperatoria
|
Author keywords
Calcineurin inhibitor; Daclizumab; Heart transplantation
|
Indexed keywords
CALCINEURIN INHIBITOR;
DACLIZUMAB;
DEFLAZACORT;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
VALGANCICLOVIR;
ACINETOBACTER INFECTION;
ACUTE KIDNEY FAILURE;
ADULT;
ARTICLE;
CARDIAC GRAFT REJECTION;
CLINICAL ARTICLE;
CONGESTIVE CARDIOMYOPATHY;
CYTOMEGALOVIRUS INFECTION;
DRUG DOSE REDUCTION;
EXTRACORPOREAL OXYGENATION;
FEMALE;
HEART MUSCLE ISCHEMIA;
HEART TRANSPLANTATION;
HUMAN;
HYPERTROPHIC CARDIOMYOPATHY;
IMMUNOSUPPRESSIVE TREATMENT;
INTENSIVE CARE UNIT;
KIDNEY FUNCTION;
LOW DRUG DOSE;
MALE;
POSTOPERATIVE PERIOD;
REPEATED DRUG DOSE;
ULTRAFILTRATION;
WOUND INFECTION;
ACUTE KIDNEY INJURY;
ADULT;
ANTIBODIES, MONOCLONAL;
CALCINEURIN;
FEMALE;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
TIME FACTORS;
|
EID: 79952446685
PISSN: 03008932
EISSN: 15792242
Source Type: Journal
DOI: 10.1016/j.recesp.2010.05.001 Document Type: Article |
Times cited : (5)
|
References (6)
|